Cite Filings / DRUG / 0000902664-25-001021

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

BRIGHT MINDS BIOSCIENCES INC. Filed 2025-02-14 Acc 0000902664-25-001021

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-02-14 EFFECT Notice of Effectiveness
2025-02-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-02-14 424B3 Prospectus
2025-02-14 6-K Report of Foreign Issuer
2025-02-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-02-12 CORRESP Correspondence Between Filers and SEC Staff
2025-02-11 UPLOAD SEC-generated Letter

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…